Apollo Funds to Acquire Covis Pharma from Cerberus

Azurity Pharmaceuticals Acquires Covis Pharma

March 14, 2025

Pharmaceuticals

Azurity Pharmaceuticals has completed its acquisition of Covis Group S.à r.l. (Covis Pharma) from existing investors, making Covis a wholly owned subsidiary of Azurity. The deal expands Azurity's therapeutic portfolio across multiple complex dosage forms and broadens its global footprint, with the combined company serving 50+ countries and employing more than 800 colleagues.

Covis Group Acquires AMAG Pharmaceuticals

November 16, 2020

Pharmaceuticals

Covis Group S.à r.l. completed a cash tender offer and merger to acquire AMAG Pharmaceuticals, Inc. for $13.75 per share, taking AMAG private and delisting its NASDAQ shares. The acquisition adds AMAG’s marketed products (including Feraheme and Makena) and development-stage assets in women’s health and hematology/oncology to Covis’ specialty pharma portfolio, supported by financing from Capital One and investment funds managed by HPS Investment Partners.

Apollo Funds to Acquire Majority Stake in Novolex

February 14, 2022

Packaging

Funds managed by Apollo affiliates have entered into a definitive agreement to acquire a majority stake in Novolex from funds managed by Carlyle, with Carlyle retaining a minority interest. Novolex, a leading sustainable packaging manufacturer headquartered in Hartsville, South Carolina with more than 10,000 employees and 57 manufacturing facilities, will look to leverage Apollo's resources to expand customer relationships, sustainability initiatives and product innovation.

ATHAGORAS Group Acquires CSO Pharma Consulting GmbH

November 18, 2024

Healthcare Services

ATHAGORAS Group has acquired CSO Pharma Consulting GmbH to expand and internationalize its pharmacovigilance, medical affairs, quality management and GDP consulting capabilities across the pharma and healthcare sectors. The deal adds a specialized provider of PV and regulatory support to ATHAGORAS' life‑sciences services platform while CSO retains focus on organic growth and continuity for clients and employees.

Provepharm Life Solutions Acquires Apollo Pharmaceuticals USA

December 2, 2020

Pharmaceuticals

Provepharm Life Solutions has acquired Apollo Pharmaceuticals USA Inc., a Florida-based commercial specialist in sterile injectable products for hospitals. The acquisition strengthens Provepharm's U.S. commercial platform and adds Apollo's four registered products, enabling faster U.S. growth and streamlined hospital-focused sales operations.

Cerberus Acquires Vivace International

February 18, 2026

Aerospace & Defense

An affiliate of Cerberus Capital Management has completed the full acquisition of Vivace International, a New Orleans–based maker of mission‑critical propulsion tanks and aerospace systems. Cerberus initially made a growth investment in 2024 and plans to scale Vivace's production capacity and advanced manufacturing capabilities to support an expanding portfolio of U.S. defense and spaceflight programs; retired Space Force Colonel and former NASA astronaut Michael Hopkins has joined Vivace as a Senior Advisor.